ResearcherVrije Universiteit BrusselActive in the last 2 years
Tao Liu
Matched on ORCID iD 0000-0001-6244-7316; OpenAlex author ID A5100338067. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 57
2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 4 papers · 2025: 1 paper
Papers 12
- SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. Co-author DOI 10.1002/mc.23936↗
- Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.freeradbiomed.2024.01.003↗
- Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. Co-author DOI 10.1038/s41698-024-00586-x↗
- Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. Co-author DOI 10.1186/s12943-024-02050-7↗
- CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. Co-author DOI 10.1186/s13046-024-03201-w↗
- Research trends and hotspots of neoadjuvant therapy in pancreatic cancer: a bibliometric analysis based on the Web of Science Core Collection. First author DOI 10.1007/s10238-023-01013-4↗
- Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fmolb.2021.745409↗
- MiR-489-3p Reduced Pancreatic Cancer Proliferation and Metastasis By Targeting PKM2 and LDHA Involving Glycolysis. Co-author DOI 10.3389/fonc.2021.651535↗
- MIB1 Upregulates IQGAP1 and Promotes Pancreatic Cancer Progression by inducing ST7 Degradation Co-author DOI 10.21203/rs.3.rs-76668/v1↗
- Circular RNA hsa_circRNA_0007334 is Predicted to Promote MMP7 and COL1A1 Expression by Functioning as a miRNA Sponge in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2019/7630894↗
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade. Co-author DOI 10.1016/j.canlet.2016.08.023↗
- Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-3359↗
Closest collaborators
The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jinxin Tao · 4 shared papers, 2024–2025 · strength 0.74
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Yifan Fu · 4 shared papers, 2024–2025 · strength 0.74
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Taiping Zhang · 4 shared papers, 2024–2025 · strength 0.74
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Wenhao Luo · 3 shared papers, 2024–2025 · strength 0.55
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Jiangdong Qiu · 3 shared papers, 2024–2025 · strength 0.55
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Yupei Zhao · 3 shared papers, 2024 · strength 0.55
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Jianchun Xiao · 2 shared papers, 2024–2025 · strength 0.35
- Hua Huang · 2 shared papers, 2024–2025 · strength 0.35
- Qiang Wang · 1 shared paper, 2024 · strength 0.21
- Omer Hany Miligy Elmadbouh · 1 shared paper, 2024 · strength 0.21
- Wei Jie Zhou · 1 shared paper, 2024 · strength 0.21
- Raul A. Urrutia · 1 shared paper, 2024 · strength 0.21
- Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.21
- Arsen Osipov · 1 shared paper, 2024 · strength 0.21
- Mouad Edderkaoui · 1 shared paper, 2024 · strength 0.21
- Zhe Cao · 1 shared paper, 2025 · strength 0.20
- Yueze Liu · 1 shared paper, 2025 · strength 0.20
- Hao Chen · 1 shared paper, 2025 · strength 0.20
- Yuanyang Wang · 1 shared paper, 2025 · strength 0.20
- Jun Wang · 1 shared paper, 2025 · strength 0.20
- Ruobing Wang · 1 shared paper, 2024 · strength 0.20
- Jiangdong Qiu · 1 shared paper, 2024 · strength 0.20
- Dan Su · 1 shared paper, 2024 · strength 0.20
- Wenhao Luo · 1 shared paper, 2024 · strength 0.20
- Hongyu Wu · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.